High treatment costs associated with oncolytic virus therapy may limit its adoption, particularly in developing regions with budget constraints.2. Limited awareness among healthcare providers and patients about the therapy's benefits and availability can hinder its market growth.Opportunities:1. Technological advancements in virology and gene therapy, along with ongoing research and development...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian